Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 150

1.

Cardiovascular hospitalizations and mortality among recipients of hematopoietic stem cell transplantation.

Chow EJ, Mueller BA, Baker KS, Cushing-Haugen KL, Flowers ME, Martin PJ, Friedman DL, Lee SJ.

Ann Intern Med. 2011 Jul 5;155(1):21-32. doi: 10.7326/0003-4819-155-1-201107050-00004.

PMID:
21727290
[PubMed - indexed for MEDLINE]
2.

Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation.

Tichelli A, Bucher C, Rovó A, Stussi G, Stern M, Paulussen M, Halter J, Meyer-Monard S, Heim D, Tsakiris DA, Biedermann B, Passweg JR, Gratwohl A.

Blood. 2007 Nov 1;110(9):3463-71. Epub 2007 Jul 30.

PMID:
17664354
[PubMed - indexed for MEDLINE]
Free Article
3.

Clostridium difficile infection after allogeneic hematopoietic stem cell transplantation: incidence, risk factors, and outcome.

Willems L, Porcher R, Lafaurie M, Casin I, Robin M, Xhaard A, Andreoli AL, Rodriguez-Otero P, Dhedin N, Socié G, Ribaud P, Peffault de Latour R.

Biol Blood Marrow Transplant. 2012 Aug;18(8):1295-301. doi: 10.1016/j.bbmt.2012.02.010. Epub 2012 Feb 28.

PMID:
22387347
[PubMed - indexed for MEDLINE]
4.

Streptococcus pneumoniae infections in 47 hematopoietic stem cell transplantation recipients: clinical characteristics of infections and vaccine-breakthrough infections, 1989-2005.

Youssef S, Rodriguez G, Rolston KV, Champlin RE, Raad II, Safdar A.

Medicine (Baltimore). 2007 Mar;86(2):69-77.

PMID:
17435587
[PubMed - indexed for MEDLINE]
5.

Polyclonal anti-thymocyte globulins for the prophylaxis of graft-versus-host disease after allogeneic stem cell or bone marrow transplantation in adults.

Theurich S, Fischmann H, Shimabukuro-Vornhagen A, Chemnitz JM, Holtick U, Scheid C, Skoetz N, von Bergwelt-Baildon M.

Cochrane Database Syst Rev. 2012 Sep 12;9:CD009159. doi: 10.1002/14651858.CD009159.pub2. Review.

PMID:
22972135
[PubMed - indexed for MEDLINE]
6.

Secondary failure of platelet recovery after hematopoietic stem cell transplantation.

Bruno B, Gooley T, Sullivan KM, Davis C, Bensinger WI, Storb R, Nash RA.

Biol Blood Marrow Transplant. 2001;7(3):154-62.

PMID:
11302549
[PubMed - indexed for MEDLINE]
7.

Prognostic factors for early severe pulmonary complications after hematopoietic stem cell transplantation.

Ho VT, Weller E, Lee SJ, Alyea EP, Antin JH, Soiffer RJ.

Biol Blood Marrow Transplant. 2001;7(4):223-9. Review.

PMID:
11349809
[PubMed - indexed for MEDLINE]
8.

Late cardiovascular events after allogeneic hematopoietic stem cell transplantation: a retrospective multicenter study of the Late Effects Working Party of the European Group for Blood and Marrow Transplantation.

Tichelli A, Passweg J, Wójcik D, Rovó A, Harousseau JL, Masszi T, Zander A, Békássy A, Crawley C, Arat M, Sica S, Lutz P, Socié G; EBMT Late Effects Working Party.

Haematologica. 2008 Aug;93(8):1203-10. doi: 10.3324/haematol.12949. Epub 2008 Jun 12.

PMID:
18556401
[PubMed - indexed for MEDLINE]
Free Article
9.

Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.

Warlick ED, Cioc A, Defor T, Dolan M, Weisdorf D.

Biol Blood Marrow Transplant. 2009 Jan;15(1):30-8. doi: 10.1016/j.bbmt.2008.10.012.

PMID:
19135940
[PubMed - indexed for MEDLINE]
10.

Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes.

Majhail NS, Parks K, Defor TE, Weisdorf DJ.

Biol Blood Marrow Transplant. 2006 Oct;12(10):1038-46.

PMID:
17067910
[PubMed - indexed for MEDLINE]
11.

Effect of conditioning regimen intensity on CMV infection in allogeneic hematopoietic cell transplantation.

Nakamae H, Kirby KA, Sandmaier BM, Norasetthada L, Maloney DG, Maris MB, Davis C, Corey L, Storb R, Boeckh M.

Biol Blood Marrow Transplant. 2009 Jun;15(6):694-703. doi: 10.1016/j.bbmt.2009.02.009. Epub 2009 Apr 16.

PMID:
19450754
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience.

Piñana JL, Valcárcel D, Martino R, Barba P, Moreno E, Sureda A, Vega M, Delgado J, Briones J, Brunet S, Sierra J.

Biol Blood Marrow Transplant. 2009 Jan;15(1):21-9. doi: 10.1016/j.bbmt.2008.10.011.

PMID:
19135939
[PubMed - indexed for MEDLINE]
13.

[Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].

Lin Q, Dong M, Wang QM, Wen JY, Wu XY.

Ai Zheng. 2006 Oct;25(10):1261-5. Chinese.

PMID:
17059772
[PubMed - indexed for MEDLINE]
14.

Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry.

Freytes CO, Loberiza FR, Rizzo JD, Bashey A, Bredeson CN, Cairo MS, Gale RP, Horowitz MM, Klumpp TR, Martino R, McCarthy PL, Molina A, Pavlovsky S, Pecora AL, Serna DS, Tsai T, Zhang MJ, Vose JM, Lazarus HM, van Besien K; Lymphoma Working Committee of the International Bone Marrow Transplant Registry.

Blood. 2004 Dec 1;104(12):3797-803. Epub 2004 Jul 27.

PMID:
15280203
[PubMed - indexed for MEDLINE]
Free Article
15.

Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation.

Abboud I, Porcher R, Robin M, de Latour RP, Glotz D, Socié G, Peraldi MN.

Biol Blood Marrow Transplant. 2009 Oct;15(10):1251-7. doi: 10.1016/j.bbmt.2009.05.016.

PMID:
19747632
[PubMed - indexed for MEDLINE]
16.

Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years.

Huisman C, Meijer E, Petersen EJ, Lokhorst HM, Verdonck LF.

Biol Blood Marrow Transplant. 2008 Feb;14(2):181-6. doi: 10.1016/j.bbmt.2007.09.017. Epub 2007 Dec 31.

PMID:
18215778
[PubMed - indexed for MEDLINE]
17.

Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.

Mengarelli A, Iori A, Guglielmi C, Romano A, Cerretti R, Torromeo C, Micozzi A, Fenu S, Laurenti L, Donato V, De Felice L, Arcese W.

Haematologica. 2002 Jan;87(1):52-8.

PMID:
11801465
[PubMed - indexed for MEDLINE]
Free Article
18.

[Clinical analysis of acute renal failure after allogeneic hematopoietic stem cell transplantation].

Zhou T, Cen XN, Qiu ZX, Ou JP, Wang WS, Xu WL, Li Y, Wang MJ, Wang LH, Tong YJ, Ren HY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Jun;17(3):723-8. Chinese.

PMID:
19549395
[PubMed - indexed for MEDLINE]
19.

Risk factors for acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation.

Yu ZP, Ding JH, Chen BA, Liu BC, Liu H, Li YF, Ding BH, Qian J.

Chin J Cancer. 2010 Nov;29(11):946-51.

PMID:
20979694
[PubMed - indexed for MEDLINE]
Free Article
20.

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

Marr KA, Carter RA, Boeckh M, Martin P, Corey L.

Blood. 2002 Dec 15;100(13):4358-66. Epub 2002 Aug 22.

PMID:
12393425
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk